New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/df/33/06/df330697-08e4-777a-946f-0efbda4dbc63/mza_13604380289617386394.jpeg/600x600bb.jpg

Touching Base

Genetic Engineering & Biotechnology News (GEN)

39 episodes

3 days ago

Touching Base is the dynamic podcast series from the editors of GEN (Genetic Engineering & Biotechnology News). Each episode features a rotating cast of senior editors including John Sterling, Kevin Davies, Julianna LeMieux, Alex Philippidis, Uduak Thomas, Corinna Singleman and Fay Lin who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next.

Hosted on Acast. See acast.com/privacy for more information.

All content for Touching Base is the property of Genetic Engineering & Biotechnology News (GEN) and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC

Touching Base

41 minutes 50 seconds

3 days ago

New Nasal Vaccines, Korro Stock Dips, J&J and Merck Acquisitions, and Dyno GATC

Nasal vaccines show new promise for human papillomavirus (HPV) to address cervical cancer and whooping cough. In business news, Korro's stock craters 81% as AATD interim Phase I/II results miss expectations. Additionally, Johnson & Johnson acquires Halda to expand their cancer pipeline while Merck acquires Cidara to boost antivirals. Lastly, the inaugural Genetic Agency Technology Conference (GATC) hosted by Dyno Therapeutics brought together a diverse group of researchers, entrepreneurs, and patient advocates to discuss the mission of genetic agency, or an individual’s ability to take action at the genetic level to live a healthier life.

Join GEN editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news.

Listed below are links to the GEN stories referenced in this episode of Touching Base:

Cervical Cancer May Be Treatable with Intranasal Nanogel Vaccine

GEN, November 15, 2025

Novel Nasal Spray Vaccine for Pertussis Shows Promise

By Corinna Singleman, PhD, GEN, November 12, 2025

StockWatch: Korro Craters 81% on Data; Patient Death Sours Analysts on Intellia

By Alex Philippidis, GENEdge, November 16, 2025

J&J Expands Cancer Pipeline with $3B Halda Acquisition

By Alex Philippidis, GENEdge, November 18, 2025

Merck to Acquire Cidara for $9.2B, Bolstering Antiviral Pipeline

By Alex Philippidis, GEN, November 15, 2025

AI Meets Genetic Agency at Dyno GATC 2025